Tjard de Cock Buning
Research Subjects
Tjard de Cock Buning has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Edith T Lammerts van Bueren
Plant Sciences Group, Wageningen University, Droevendaalsesteeg 1, PO Box 386, 6700 AJ Wageningen, The Netherlands
1 shared publicationHuib C de Vriend
LIS Consult, Laan van Hoornwijck 1, 2289 DG Rijswijk, The Netherlands
1 shared publicationJacqueline E.W. Broerse
1 shared publicationJoske F.G. Bunders
1 shared publicationMichel A Haring
Plant Physiology, University of Amsterdam, Kruislaan 318, 1098 SM Amsterdam, The Netherlands
1 shared publicationPaul C Struik
Plant Sciences Group, Crop and Weed Ecology, Wageningen University, PO Box 430, 6700 AK Wageningen, The Netherlands
1 shared publication
Latest Publications
- 30 October 2009
- Published by Walter de Gruyter GmbH
- p. 135-141
Comparative analysis of the inclusion of animal ethics in European animal welfare policy-making
A comparative analysis of the inclusion of animal ethics in animal welfare policy-making in four European countries (Austria, the Netherlands, Norway and the United Kingdom) reveals several similarities and differences in national experiences. This analysis shows that considerable similarities exist with respect to the framing of ethical issues in animal welfare policy-making. All four study countries have adopted quite similar animal welfare legislation that is further specified in guidelines and codes of practice. Probably the most interesting difference between the four countries concerns the interpretation and relative weight of the notion of enhancing natural behaviour in animal welfare legislation. The UK explicitly opted to reformulate this notion of behaviour as set out by the Brambell Committee into normal behaviour, thus introducing current farming practices rather than nature as the benchmark for measuring welfare. In Norway, natural behaviour refers somewhat ambivalently to either behaviour that can be observed in a species’ wild relatives or in the animals when placed in natural or semi-natural environments. Austria and The Netherlands opted to embrace the notion of natural behaviour as one of the main guiding principles in animal welfare legislation but struggle with the application in more specified guidelines and codes of practice.
- 30 October 2009
- Published by Walter de Gruyter GmbH
- p. 135-141
Comparative analysis of the inclusion of animal ethics in European animal welfare policy-making
A comparative analysis of the inclusion of animal ethics in animal welfare policy-making in four European countries (Austria, the Netherlands, Norway and the United Kingdom) reveals several similarities and differences in national experiences. This analysis shows that considerable similarities exist with respect to the framing of ethical issues in animal welfare policy-making. All four study countries have adopted quite similar animal welfare legislation that is further specified in guidelines and codes of practice. Probably the most interesting difference between the four countries concerns the interpretation and relative weight of the notion of enhancing natural behaviour in animal welfare legislation. The UK explicitly opted to reformulate this notion of behaviour as set out by the Brambell Committee into normal behaviour, thus introducing current farming practices rather than nature as the benchmark for measuring welfare. In Norway, natural behaviour refers somewhat ambivalently to either behaviour that can be observed in a species’ wild relatives or in the animals when placed in natural or semi-natural environments. Austria and The Netherlands opted to embrace the notion of natural behaviour as one of the main guiding principles in animal welfare legislation but struggle with the application in more specified guidelines and codes of practice.
- 1 January 2008
- Published by S. Karger AG in Public Health Genomics
- Vol. 11 (1) , 52-62
Public Perception of Prenatal Genetic Testing: Arguments Put forward by the Public during a Participatory Policy Project in the Netherlands
In early 2002, the Dutch Ministry of Public Health, Welfare and Sport piloted the application of an interactive process to policy development in the field of medical biotechnology. In such an approach, relevant societal actors, including the public at large, are actively involved in an open exchange, planning, action and reflection process. This paper reports on the findings of one of the activities of the ministry within this initiative, the consultation of the public on dilemmas with respect to prenatal genetic testing by means of citizen panels. Participants were asked to reflect on questions with respect to whether and under which conditions pregnant women may have freedom of choice to use prenatal genetic testing. In a structured way, arguments in favour and against various positions were identified and prioritized. The paper closes with a discussion on the implications of the use of citizen panels and summarizes the 2 actual policy changes of the ministry that resulted from this process.
- 1 January 2008
- Published by S. Karger AG in Public Health Genomics
- Vol. 11 (1) , 52-62
Public Perception of Prenatal Genetic Testing: Arguments Put forward by the Public during a Participatory Policy Project in the Netherlands
In early 2002, the Dutch Ministry of Public Health, Welfare and Sport piloted the application of an interactive process to policy development in the field of medical biotechnology. In such an approach, relevant societal actors, including the public at large, are actively involved in an open exchange, planning, action and reflection process. This paper reports on the findings of one of the activities of the ministry within this initiative, the consultation of the public on dilemmas with respect to prenatal genetic testing by means of citizen panels. Participants were asked to reflect on questions with respect to whether and under which conditions pregnant women may have freedom of choice to use prenatal genetic testing. In a structured way, arguments in favour and against various positions were identified and prioritized. The paper closes with a discussion on the implications of the use of citizen panels and summarizes the 2 actual policy changes of the ministry that resulted from this process.
- 1 November 2006
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (11) , 1329-1331
'Cisgenic' as a product designation
- 1 November 2006
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (11) , 1329-1331
'Cisgenic' as a product designation
- 1 January 2004
- Published by SAGE Publications in Alternatives to Laboratory Animals
- Vol. 32 (1_suppl) , 459-463
Practical Difficulties in Balancing Harms and Benefits in the Modern Use of Laboratory Animals: Biotechnology
Every ethical review process presupposes a set of ethical criteria, proper procedures and a consistent legal framework. The Netherlands became unique in 1996, by the decision of the Parliament to start a national ethical review procedure regarding the ethical aspects of genetic modification of animals (Animal and Biotechnology Decree). Due to the policy of public disclosure of all relevant documents and providing a legal trajectory for public objections, extensive ethical arguments pro and con are well documented. This paper lists and analyses the misconceptions when one tries to apply the “classical” ethical framework of harms and benefits to the new designs of animal experiments in the context of biotechnology. For instance, what is the object? The foster mothers, the manipulated egg cell, the malformed embryo, the pups dying before weaning or the adult mice in the experiments? The public considers the whole methodology ethically relevant. Most researchers tend to check out only “consciously” experienced harm, which implies only autonomously living mice and not a cell or an embryo. And, what is the domain of benefits? An exciting construct to be incorporated in the genome, the healthy birth of a surviving knock out, or a successful experiment with adult genetically modified mice? In the same way, the question for relevant alternatives in the “classic” sense of the Three Rs seems to shift completely to a discussion about goals in the far future. Is this modification absolutely necessary, or are the goals also reached by research strategies without genetic modification?
- 1 January 2004
- Published by SAGE Publications in Alternatives to Laboratory Animals
- Vol. 32 (1_suppl) , 459-463
Practical Difficulties in Balancing Harms and Benefits in the Modern Use of Laboratory Animals: Biotechnology
Every ethical review process presupposes a set of ethical criteria, proper procedures and a consistent legal framework. The Netherlands became unique in 1996, by the decision of the Parliament to start a national ethical review procedure regarding the ethical aspects of genetic modification of animals (Animal and Biotechnology Decree). Due to the policy of public disclosure of all relevant documents and providing a legal trajectory for public objections, extensive ethical arguments pro and con are well documented. This paper lists and analyses the misconceptions when one tries to apply the “classical” ethical framework of harms and benefits to the new designs of animal experiments in the context of biotechnology. For instance, what is the object? The foster mothers, the manipulated egg cell, the malformed embryo, the pups dying before weaning or the adult mice in the experiments? The public considers the whole methodology ethically relevant. Most researchers tend to check out only “consciously” experienced harm, which implies only autonomously living mice and not a cell or an embryo. And, what is the domain of benefits? An exciting construct to be incorporated in the genome, the healthy birth of a surviving knock out, or a successful experiment with adult genetically modified mice? In the same way, the question for relevant alternatives in the “classic” sense of the Three Rs seems to shift completely to a discussion about goals in the far future. Is this modification absolutely necessary, or are the goals also reached by research strategies without genetic modification?